Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darin Edwards

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Infectious Diseases|January 10, 2025
Safety and Immunogenicity of SARS-CoV-2 Spike Receptor-Binding Domain and N-Terminal Domain mRNA VaccineSpyros Chalkias, Antionette Pragalos, Adebayo Akinsola, et al.
Vaccine|March 8, 2025
mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in miceDiana Wing Lee, Arshan Nasir, Sayda Elbashir, et al.
Frontiers in Immunology|November 25, 2022
Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in miceDario Garcia-Dominguez, Carole Henry, LingZhi Ma, et al.
NPJ Vaccines|June 30, 2022
Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticleJennifer N Rainho-Tomko, Vincent Pavot, Michael Kishko, et al.
Science Immunology|May 3, 2020
A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domainKurt A Swanson, Jennifer N Rainho-Tomko, Zachary P Williams, et al.
Science Immunology|June 16, 2021
SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaquesCarolina Garrido, Alan D Curtis, Maria Dennis, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
SARS-CoV-2 Vaccines Elicit Durable Immune Responses in Infant Rhesus MacaquesCarolina Garrido, Alan D Curtis, Maria Dennis, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challengeMichelle Meyer, Yuan Wang, Darin Edwards, et al.
The Journal of Clinical Investigation|August 27, 2021
Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infectionMichelle Meyer, Yuan Wang, Darin Edwards, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Phylogeny-driven design of broadly protective sarbecovirus receptor-binding domain nanoparticle vaccinesAmin Addetia, Alexandra Schäfer, Kaitlin Sprouse, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Infectious Diseases|January 10, 2025
Safety and Immunogenicity of SARS-CoV-2 Spike Receptor-Binding Domain and N-Terminal Domain mRNA VaccineSpyros Chalkias, Antionette Pragalos, Adebayo Akinsola, et al.
Vaccine|March 8, 2025
mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in miceDiana Wing Lee, Arshan Nasir, Sayda Elbashir, et al.
Frontiers in Immunology|November 25, 2022
Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in miceDario Garcia-Dominguez, Carole Henry, LingZhi Ma, et al.
NPJ Vaccines|June 30, 2022
Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticleJennifer N Rainho-Tomko, Vincent Pavot, Michael Kishko, et al.
Science Immunology|May 3, 2020
A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domainKurt A Swanson, Jennifer N Rainho-Tomko, Zachary P Williams, et al.
Science Immunology|June 16, 2021
SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaquesCarolina Garrido, Alan D Curtis, Maria Dennis, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
SARS-CoV-2 Vaccines Elicit Durable Immune Responses in Infant Rhesus MacaquesCarolina Garrido, Alan D Curtis, Maria Dennis, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challengeMichelle Meyer, Yuan Wang, Darin Edwards, et al.
The Journal of Clinical Investigation|August 27, 2021
Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infectionMichelle Meyer, Yuan Wang, Darin Edwards, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Phylogeny-driven design of broadly protective sarbecovirus receptor-binding domain nanoparticle vaccinesAmin Addetia, Alexandra Schäfer, Kaitlin Sprouse, et al.
Pageof 3